Literature DB >> 15696462

Chronic kidney disease: stemming the global tide.

Emeka Nwankwo, Aminu K Bello, A Meguid El Nahas.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15696462     DOI： 10.1053/j.ajkd.2004.09.005

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  7 in total

1.  Altitude and regional gradients in chronic kidney disease prevalence in Costa Rica: Data from the Costa Rican Longevity and Healthy Aging Study.

Authors:  Meera N Harhay; Michael O Harhay; Fernando Coto-Yglesias; Luis Rosero Bixby
Journal:  Trop Med Int Health       Date:  2015-11-12       Impact factor: 2.622

2.  Occupational exposures and chronic kidney disease: Possible associations with endotoxin and ultrafine particles.

Authors:  Todd R Sponholtz; Dale P Sandler; Christine G Parks; Katie M Applebaum
Journal:  Am J Ind Med       Date:  2015-11-17       Impact factor: 2.214

3.  Final year nursing students in Nigeria; How knowledgeable and prepared are they to offer medical care to patients with chronic kidney disease?

Authors:  Chimezie Godswill Okwuonu; Hannah Sylvanus Kanu; Ojeh-Oziegbe Odigie
Journal:  Ann Afr Med       Date:  2017 Jan-Mar

4.  Prevalence of Early Chronic Kidney Disease and Main Associated Factors in Spanish Population: Populational Study.

Authors:  Carmen Expósito; Guillem Pera; Lluís Rodríguez; Ingrid Arteaga; Alba Martínez; Alba Alumà; María Doladé; Pere Torán; Llorenç Caballeria
Journal:  J Clin Med       Date:  2019-09-04       Impact factor: 4.241

5.  Kidney Disease Knowledge and Its Determinants Among Patients With Chronic Kidney Disease.

Authors:  Roland Nnaemeka Okoro; Ibrahim Ummate; John David Ohieku; Sani Ibn Yakubu; Maxwell Ogochukwu Adibe; Mathew Jegbefume Okonta
Journal:  J Patient Exp       Date:  2020-10-21

6.  Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver.

Authors:  Simone K Frey; Britta Nagl; Andrea Henze; Jens Raila; Beate Schlosser; Thomas Berg; Martin Tepel; Walter Zidek; Martin O Weickert; Andreas F H Pfeiffer; Florian J Schweigert
Journal:  Lipids Health Dis       Date:  2008-08-27       Impact factor: 3.876

7.  JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.

Authors:  Katherine R Tuttle; Frank C Brosius; Sharon G Adler; Matthias Kretzler; Ravindra L Mehta; James A Tumlin; Yoshiya Tanaka; Masakazu Haneda; Jiajun Liu; Maria E Silk; Tracy E Cardillo; Kevin L Duffin; Joseph V Haas; William L Macias; Fabio P Nunes; Jonathan M Janes
Journal:  Nephrol Dial Transplant       Date:  2018-11-01       Impact factor: 5.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.